Biotech Pre-Seed Investors & VC Firms
915 firms in this list, with a median first check of $250K. 237 of them lead rounds. Generated from verified public data and updated continuously.
AmorChem
MontrealPre-Seed–Series A
5 people
Clarus Ventures
Menlo ParkPre-Seed–Late Stage
8 people
Atria Ventures
San FranciscoPre-Seed–Seed$500K – $3M
1 person
IDB Lab
Washington, D.C.Pre-Seed–Series B
7 people
Proofpoint Capital
PhoenixvillePre-Seed–Seed
7 people
Louisiana Funds
Baton RougePre-Seed–Seed
3 people
Carbon Silicon
Carson CityPre-Seed–Series A$100K – $500K
2 people
Gossamer Capital
DenverPre-Seed–Seed
2 people
Redstart Labs
IndiaPre-Seed–Series A
2 people
1921 Ventures
ViennaPre-Seed–Series A$200K – $1.5M
1 person
Global Startups Accelerator (formerly LatAm Startups)
TorontoPre-Seed–Seed
8 people
Improve Ventures
BarcelonaPre-Seed–Series A$100K – $1M
5 people
NewMargin Ventures
ShanghaiPre-Seed–Series B$500K – $5M
5 people
QB Capital
FukuokaPre-Seed–Series A
8 people
Top Harvest Capital
Menlo ParkPre-Seed–Series A
5 people
Venture
ZurichPre-Seed–Series B
8 people
Israel Innovation Authority
JerusalemPre-Seed–Growth
2 people
Mystic Ventures
LynnwoodPre-Seed–Series A
3 people
Cambridge Capital Group
CambridgePre-Seed–Series A$10K – $2M
1 person
HEARTFELT_
BerlinPre-Seed–Seed$110K – $440K
1 person
Eastend Ventures
AdelaidePre-Seed–Series A
4 people
HARPER COURT VENTURES
ChicagoPre-Seed–Series A
4 people
AYANA Capital LLC
TampaPre-Seed–Series A$1M – $3M
2 people
Excell Partners
RochesterPre-Seed–Series A$100K – $1.5M
3 people
Related lists
Pre-Seed Investors & VC Firms (5569)Pre-Seed Investors & VC Firms in North America (3004)Pre-Seed Investors & VC Firms in United States (2671)Biotech Investors & VC Firms (2475)AI & Machine Learning Pre-Seed Investors & VC Firms (2102)Biotech Seed Investors & VC Firms (2020)Fintech Pre-Seed Investors & VC Firms (1711)SaaS Pre-Seed Investors & VC Firms (1652)Biotech Series A Investors & VC Firms (1626)Pre-Seed Investors & VC Firms in Europe (1598)
Data sourced from public filings and firms' own websites — see our methodology.

































































